Amarantus Bioscience Holdings, Inc.(Other OTC/NBB : AMBS)
AMBS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Loading AMBS News...
Health Technology » Biotechnology
Amarantus BioScience Holdings, Inc. is a publicly traded biotechnology company focused on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in San Francisco, CA.